Symptoms and circuits, Part 3: Schizophrenia

Journal of Clinical Psychiatry

Volumn 65, Issue 1, 2004, Pages 8-9

  Stahl, Stephen M ^a,b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

AFFECT; BRAIN CORTEX; COGNITION; DIFFERENTIAL DIAGNOSIS; HALLUCINATION; HUMAN; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; REVIEW; SCHIZOPHRENIA;

AFFECT; CEREBRAL CORTEX; COGNITION; DIAGNOSIS, DIFFERENTIAL; HALLUCINATIONS; HUMANS; NEURONS; NEUROTRANSMITTER AGENTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 1442309143     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0102     Document Type: Short Survey

References (7)

1. Stahl SM. Deconstructing psychiatric disorders, pt 1: genotypes, symptom phenotypes, and endophenotypes [BRAINSTORMS]. J Clin Psychiatry 2003;64:982-983 (Pubitemid 37158241)
2. Stahl SM. Deconstructing psychiatric disorders, pt 2: an emerging, neurobiologically based therapeutic treatment strategy for the modern psychopharmacologist [BRAINSTORMS]. J Clin Psychiatry 2003;64:1145-1146
3. Stahl SM. Symptoms and circuits, pt 1: major depressive disorder [BRAINSTORMS]. J Clin Psychiatry 2003;64:1282-1283 (Pubitemid 37490231)
4. Stahl SM. Symptoms and circuits, pt 2: anxiety disorders [BRAINSTORMS]. J Clin Psychiatry 2003;64:1408-1409 (Pubitemid 41270096)
5. Stahl SM. Essential Psychopharmacology of Antipsychotics and Mood Stabilizers. New York, NY: Cambridge University Press; 2002
6. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val 108/158 Met genotype of frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001;98:6917-6922 (Pubitemid 32538317)
7. Stahl SM, Shayegan DK. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatry 2003;65(suppl 19):6-12